Clinical Trial Update: Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain

View source ↗

Summary

Post-marketing study in Spain assessing clinical outcomes in asthma patients treated with tezepelumab after marketing approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED